Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy
El Sayed, A., Ibrahim, W., El Badawy, A., El. Araby, M., Abd Elmoniem, R. (2023). Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy. EKB Journal Management System, 91(1), 4505-4510. doi: 10.21608/ejhm.2023.296754
Amira M. El Sayed; Walaa M. Ibrahim; Ayman M. El Badawy; Marwa M El. Araby; Rasha O. Abd Elmoniem. "Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy". EKB Journal Management System, 91, 1, 2023, 4505-4510. doi: 10.21608/ejhm.2023.296754
El Sayed, A., Ibrahim, W., El Badawy, A., El. Araby, M., Abd Elmoniem, R. (2023). 'Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy', EKB Journal Management System, 91(1), pp. 4505-4510. doi: 10.21608/ejhm.2023.296754
El Sayed, A., Ibrahim, W., El Badawy, A., El. Araby, M., Abd Elmoniem, R. Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy. EKB Journal Management System, 2023; 91(1): 4505-4510. doi: 10.21608/ejhm.2023.296754

Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy

The Egyptian Journal of Hospital Medicine
Article 114, Volume 91, Issue 1, April 2023, Page 4505-4510  XML PDF (489.36 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2023.296754
View on SCiNiTO View on SCiNiTO
Authors
Amira M. El Sayed; Walaa M. Ibrahim; Ayman M. El Badawy; Marwa M El. Araby; Rasha O. Abd Elmoniem
Abstract
Background: Angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism has been linked to diabetes and the progression of diabetic comorbidities.
Objectives: Study the correlation between the ACE I/D gene polymorphism and: a) Risk of development of type 2 diabetes mellitus (T2DM) in Egyptian population. b) Development of diabetic nephropathy.
Patients and methods: we studied80 participants: including 20 healthy participants, and 60 patients with diabetes. The following laboratory tests were performed: HA1C, lipid profile, estimated glomerular filteration rate (eGFR), serum creatinine, urine analysis, urine albumin creatinine ratio, DNA Isolation and Determination of ACE Genotype(GT) were performed to all patients and control subjects.
Results: In diabetic patients about 81 % had Genotypes II and 18.3% had Genotype ID, while in control group 95 % had genotype II. In diabetics without chronic kidney disease (CKD) 96 % had genotype II and about 3 % had genotype ID. In diabetics with CKD about 66 % had genotypes II while 33 % had genotype ID. There was a significant difference found in the studied groups, p was 0.033. the mean HbA1c, GFR and creatinine in diabetics with chronic kidney disease with genotype II was 7.81,22.57 and 4.08 respectively, while the mean HbA1c, GFR and creatinine in diabetic chronic kidney with genotype ID was 8.92, 13.44 and 5.02 respectively. There was significant difference found in the studied groups according to GFR, p was 0.005.
Conclusion The current study demonstrated that; ACE gene I/D polymorphism has potential link to DM and progression to diabetic nephropathy.
 
Keywords
Diabetic chronic kidney; ACE; Insertion/deletion polymorphism
Statistics
Article View: 183
PDF Download: 393